NCT02173574View on ClinicalTrials.gov

Two-way Interaction Between Alisporivir and EDP239

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Hepatitis C Virus
Interventions
DRUG

DEB025

DRUG

EDP239

Trial Locations (1)

14050

Investigative Site, Berlin

Sponsors
All Listed Sponsors
lead

Enanta Pharmaceuticals, Inc

INDUSTRY

NCT02173574 - Two-way Interaction Between Alisporivir and EDP239 | Biotech Hunter | Biotech Hunter